Use of GLP-1s is linked to lower risk for subarachnoid hemorrhage and mortality in patients with intracranial aneurysms and type 2 diabetes compared to use of other agents, a new study shows.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/glp-1s-linked-reduced-bleeding-risk-intracranial-aneurysms-2026a10003ai?src=rss
Author :
Publish date : 2026-02-03 05:14:00
Copyright for syndicated content belongs to the linked Source.
